Coronary atherosclerotic status in women with postmenopausal osteoporosis research hub

Effect of Romosozumab vs. Denosumab on Coronary Atherosclerotic Damage in Postmenopausal Osteoporotic Women: A Phase IV, Low-Risk, Pharmacological Intervention Study. ATRIO Study.

This study looks at how two common osteoporosis medicines, Evenity and Prolia, affect the heart and blood vessels in postmenopausal women. Researchers want to see if these treatments change the amount of hardening in the arteries around the heart over 12 months.